相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma
Kazuhiro Kasai et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis
H. Nagamatsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Phase 2 Open-label Study of Single-agent Sorafenib in Treating Advanced Hepatocellular Carcinoma in a Hepatitis B-endemic Asian Population
Thomas Yau et al.
CANCER (2009)
Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results
Kazuhiro Kasai et al.
HEPATOLOGY RESEARCH (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatocellular carcinoma with portal vein tumor thrombosis: Clinical characteristics, prognosis, and patient survival analysis
Daichi Takizawa et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
S Obi et al.
CANCER (2006)
Natural history of untreated nonsurgical hepatocellular carcinoma
YP Yeung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein
T Itamoto et al.
JOURNAL OF SURGICAL ONCOLOGY (2002)
Combined Intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
M Sakon et al.
CANCER (2002)
Interferon-α delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases
D Murphy et al.
HEPATOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
P Glue et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Identification of the major positional isomer of pegylated interferon alpha-2b
YS Wang et al.
BIOCHEMISTRY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
